Bright Path Pharmaceuticals, LLC (privately held) today announced that Todd N. Smith, Chairman and CEO of Novum Pharma will join the Board. Mr. Smith has twenty-five years of pharmaceutical, medical device and biotechnology general management experience and a long track record of building companies and achieving commercial and business development excellence.
Mr. Smith served as Executive Vice President and Chief Commercial Officer at Horizon Pharma where he was instrumental in building and executing the commercial model and Business Development strategy that increased Horizon’s market cap from $200M to $5B. Mr. Smith has led and participated in 25+ product launches including several billion dollar brands and product portfolios, and has built high-performing commercial teams at top companies including Bayer, Abbott, Horizon Pharma, Agouron and Fenwal Inc.
Mr. Quinones elated stated, “We are determined to recruit the best talent to our Board and Todd possesses the type of leadership we need.” Mr. Allen affirmed, “Todd is fine pharma executive, the best, and his skills in the pharma business are only exceeded by his personal character and integrity.”